Introduction to Leukotriene Drugs

Leukotriene drugs are a class of medications primarily used to manage asthma and allergic rhinitis. Understanding how these drugs are absorbed, distributed, metabolized, and excreted in the body is essential for optimizing their therapeutic effects and minimizing side effects.

Introduction to Leukotriene Drugs

Leukotriene receptor antagonists, such as montelukast and zafirlukast, block the action of leukotrienes—chemical mediators involved in inflammatory responses. These drugs are taken orally and require proper pharmacokinetic understanding to ensure effective treatment.

Absorption of Leukotriene Drugs

Leukotriene drugs are absorbed primarily through the gastrointestinal tract after oral administration. Factors influencing absorption include the drug’s formulation, gastric pH, and presence of food. For example, montelukast has high bioavailability and is well-absorbed with or without food.

Factors Affecting Absorption

• Gastrointestinal pH
• Food intake
• Drug formulation
• Gastrointestinal motility

Distribution of Leukotriene Drugs

After absorption, leukotriene drugs are distributed throughout the body via the bloodstream. They tend to bind extensively to plasma proteins, which influences their distribution volume and duration of action.

Protein Binding

• High plasma protein binding (>99%)
• Impacts free drug concentration
• Can affect drug interactions

Metabolism of Leukotriene Drugs

Leukotriene drugs are primarily metabolized in the liver. Montelukast undergoes extensive hepatic metabolism via the cytochrome P450 enzyme system, especially CYP3A4 and CYP2C9.

Metabolic Pathways

• Hepatic oxidation
• Conjugation reactions
• Formation of inactive metabolites

Excretion of Leukotriene Drugs

Excretion occurs mainly through the feces and urine. The inactive metabolites are eliminated via renal and biliary routes, with a small fraction of the unchanged drug excreted in urine.

Elimination Half-life

• Montelukast: approximately 3-6 hours
• Zafirlukast: approximately 10 hours
• Impacts dosing frequency

Understanding these pharmacokinetic processes assists clinicians in optimizing dosing schedules, managing potential drug interactions, and predicting patient responses to leukotriene therapy.